NasoNeb®

Making lives better since 2009 NasoNeb® Nasal Delivery Systems (NDS), now a division of Monaghan Medical Corporation, is a global developer and manufacturer of intranasal drug delivery systems inspired by ENT clinics and designed with healthcare specialists in mind. The flagship product, NasoNeb® Sinus Therapy System, is a powered nasal nebulizer that delivers a high concentration of medication throughout the nasal and paranasal cavities to deliver fast and efficient relief for sinus and rhinitis patients. NasoNeb® is committed to working with physicians, hospitals, and patients globally to break down barriers to wellness and help people feel better and breathe better. How it Works The NasoNeb® Sinus Therapy System is a nasal solution delivery device that helps you fight sinus infections, nasal polyps, allergy symptoms, and improve your nasal hygiene by allowing you to: - Choose the solution you want to deliver to your nasal cavities such as saline for irrigation, moisturizers for dry nose or prescriptions to fight bacteria or infection as directed by a Doctor - Get unmatched, powered aerosol coverage that sprays, pumps and netipots cannot provide while remaining gentle, quick and comfortable. Community Located in Plattsburgh, NY, USA, NasoNeb® NDS is a division of Monaghan Medical Corporation. Monaghan Medical and its affiliates are global leaders in the development and manufacture of innovative, high quality, patient-oriented aerosol drug delivery devices and respiratory management products including the AeroChamber® brand of spacers, the Aerobika® brand of OPEP devices, and the AeroEclipse® brand of nebulizers. With the support of a state-of-the-art aerosol research laboratory, our mission is to provide patients and caregivers - as well as major pharmaceutical companies engaged in respiratory medicine throughout the world—with the most advanced, therapeutic, and cost-effective product solutions available.

• Employees 3
• Founded 2009
• Annual Revenue $29716000